A detailed history of S.A. Mason LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, S.A. Mason LLC holds 1,500 shares of VKTX stock, worth $78,885. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,600 6.25%
Holding current value
$78,885
Previous $84,000 11.9%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$49.84 - $70.47 $4,984 - $7,047
-100 Reduced 6.25%
1,500 $94,000
Q2 2024

Jul 10, 2024

BUY
$47.39 - $80.2 $75,824 - $128,320
1,600 New
1,600 $84,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track S.A. Mason LLC Portfolio

Follow S.A. Mason LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.